SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Pfizer Reports Infection Rates for Elrexfio Patients Versus Investigator’s Choice

Grade 3+ infections occurred in 27.5% of Elrexfio patients versus 18.1% with investigator’s choice; grade 5 infections were 0.8% versus 1.6%.

PFE

Related stories